Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	14.89	77.42	67.38
Graham Fair Price	10.56	2213.28	2001.89
PEG	235.30	1.28	-0.38
Price/Book	-0.80	1.60	1.61
Price/Cash Flow	30.60	43.88	-33.60
Prices/Earnings	-12.28	22.55	25.71
Price/Sales	17.11	2.53	2.16
Price/FCF	30.60	43.88	-33.60
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	4.99	0.15	0.14
Operating Margin	-9.51	0.03	0.03
ROA	17.80	< 0.005	< 0.005
ROE	0.02	0.02	13.08
ROIC	0.01	0.01	13.37
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.09	0.18	-51.17
Dividends QOQ	14.48	-0.94	-93.54
EBIT QOQ	-0.40	-0.20	50.32
EPS QOQ	-0.67	0.18	-73.84
FCF QOQ	0.17	1.79	955.83
Revenue QOQ	-0.03	-0.12	-336.52
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	116.14	142.48	22.68
Days Sales Outstanding (DSO)	77.66	93.13	19.93
Inventory Turnover	0.77	0.63	-18.49
Debt/Capitalization	0.39	0.35	-8.63
Quick Ratio	0.98	1.00	2.08
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	3373.38	3507.20	3.97
Cash	869.14	828.12	-4.72
Capex	-22.80	-11.54	49.36
Free Cash Flow	-161.60	127.61	-21.03
Revenue	2517.21	2216.73	-11.94
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.08	2.06	-1.15
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.76	12.83	0.56
Naive Interpretation	Member

06 - Financial Health · Bad

Rating